Top Read Articles

    Published in last 1 year |  In last 2 years |  In last 3 years |  All
    Please wait a minute...
    For Selected: Toggle Thumbnails
    Interpretation of ‘clinical obesity: definition and diagnostic criteria’ from the Lancet Diabetes & Endocrinology Commission
    ZHANG Peng, ZHANG Zhongtao
    Journal of Surgery Concepts & Practice    2025, 30 (03): 192-196.   DOI: 10.16139/j.1007-9610.2025.03.02
    Abstract632)   HTML20)    PDF(pc) (873KB)(383)       Save

    The current diagnostic criteria for obesity are based on body mass index (BMI). However, BMI does not directly reflect fat accumulation or its adverse health effects, making it inadequate for clinical needs. In response, the Lancet Diabetes & Endocrinology Commission has proposed a refined definition and diagnostic criteria of obesity, including Pre-clinical Obesity which is defined as having only abnormal anthropometric indicators, thus only lifestyle interventions is recommended to improve body composition and reduce disease risk; as well as Clinical Obesity which is diagnosed when abnormal anthropometric indicators are accompanied by obesity-related comorbidities or limitations in daily activities, necessitating active medical intervention. While several academic societies have raised concerns that this classification may reclassify some obesity cases from a disease state to a risk factor, potentially depriving patients of treatment opportunities, the new criteria overall represents a significant advancement in enabling more precise diagnosis and management of obesity, based on fat accumulation and its impact on organ function.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Impact of miR-4674 expression changes on the biological characteristics of BGC-823 gastric cancer cell line
    YUAN Xiaobing, ZHU Jianwei
    Journal of Surgery Concepts & Practice    2025, 30 (04): 295-301.   DOI: 10.16139/j.1007-9610.2025.04.02
    Abstract585)   HTML8)    PDF(pc) (3825KB)(124)       Save

    Objective To explore the impact of miR-4674 expression changes on the biological characteristics of BGC-823 gastric cancer cell line based on bioinformatics research. Methods Through bioinformatics screening, miR-4674 was prioritized as a gastric cancer-associated miRNA. We constructed miR-4674 mimic, inhibitor, and corresponding negative control (NC) transfected into the BGC-823 cell line. Reverse transcription-polymerase chain reaction (RT-PCR) method was used to detect the expression changes of miR-4674 in BGC-823 cells. Functional assays included: MTT assay for cell proliferation ability; Transwell assay for migration capacity; TUNEL staining for cell apoptosis detection.Results Compared with the control group and cells transfected with NC, the level of miR-4674 was significantly increased in cells transfected with miR-4674 mimic, and the proliferation and migration abilities of the cells were significantly improved (P< 0.05). In cells transfected with miR-4674 inhibitor, the level of miR-4674 was significantly decreased, and the proliferation and migration abilities of the cells were significantly reduced (P<0.05). The result of TUNEL showed no significant differences in apoptotic rates were observed across all groups. Conclusions In the BGC-823 gastric cancer cell line, inhibition of miR-4674 expression can reduce its malignancy, while overexpression of miR-4674 can enhance its malignancy, suggesting its potential as a therapeutic target for gastric cancer intervention, providing a new strategy for the treatment of gastric cancer.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Expression and clinical significance of KIF15, EGFR, and HER2 in gallbladder cancer
    WANG Jun, WANG Lubing, HU Gangfeng, ZHANG Bo, HUANG Xia, HUANG Lei
    Journal of Surgery Concepts & Practice    2025, 30 (05): 409-416.   DOI: 10.16139/j.1007-9610.2025.05.06
    Abstract553)   HTML6)    PDF(pc) (5348KB)(171)       Save

    Objective To investigate the expression of kinesin family member 15(KIF15), epidermal growth factor receptor(EGFR), and human epidermal growth factor receptor 2(HER2) in gallbladder cancer(GBC) and their clinical and pathological significance. Methods Immunohistochemical staining was employed to detect the expression of KIF15, EGFR, and HER2 proteins in GBC tissue microarrays. The correlation between protein expression levels and various clinical and pathological characteristics of GBC patients was analyzed. Results The positive expression rates of KIF15, EGFR, and HER2 proteins in GBC tissues were 71.6%, 62.2%, and 51.4% respectively, compared to 16.7%, 0, and 0 in para-carcinoma tissues (all P=0.000). KIF15 expression was correlated with cancer differentiation grade (P=0.006), while EGFR expression was associated with lymph node metastasis(P=0.026) and the number of metastatic lymph nodes(P=0.012). HER2 expression was correlated with cancer differentiation grade(P=0.018), tumor size(P=0.005), and T stage(P=0.032). GBC patients with co-positive expression of KIF15 and HER2 had significantly lower overall survival compared to those with negative expression. Positive HER2 expression, lymph node metastasis, and the number of metastatic lymph nodes were identified as independent risk factors for overall survival in GBC patients. Conclusions Positive expression of KIF15, EGFR, and HER2 in GBC tissues are correlated with various clinical indicators and poorer prognosis. These proteins may serve as potential factors for predicting prognosis and evaluating therapeutic efficacy in GBC.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Asian consensus on normothermic intraperitoneal and systemic treatment for gastric cancer with peritoneal metastasis
    ZHU Zhenggang, Joji Kitayama, Hyung-Ho Kim, Jimmy Bok-Yan So, CAO Hui, CHEN Lin, CHENG Xiangdong, HU Jiankun, Motohiro Imano, Hironori Ishigami, Ye Seob Jee, Jong-Han Kim, Yasuhiro Kodera, LIANG Han, LIU Xiaowen, LU Sheng, MOU Yiping, NIE Mingming, Won Jun Seo, WANG Yanong, WU Dan, XU Zekuan, Hironori Yamaguchi, YAN Chao, YANG Zhongyin, YIN Kai, Yutaka Yonemura, Wei-Peng Yong, YU Jiren, ZHANG Jun, Asian Gastric Cancer NIPS Treatment Collaborative Group, Shanghai Anticancer Association, Committee of Peritoneal Tumor
    Journal of Surgery Concepts & Practice    2025, 30 (04): 277-294.   DOI: 10.16139/j.1007-9610.2025.04.01
    Abstract514)   HTML23)    PDF(pc) (1637KB)(406)       Save

    Gastric cancer with peritoneal metastasis (GCPM) is a common and lethal manifestation of advanced gastric cancer, with a median survival of only 5-11 months. This consensus was developed by 30 experts from Asia (China, Japan, Korea, and Singapore) using the Delphi method and the GRADE evidence grading system. A total of 29 statements were formulated, covering the diagnosis and assessment of GCPM, indications for laparoscopic exploration and NIPS (normothermic intraperitoneal and systemic treatment), treatment regimens, prevention and management of complications, criteria for conversion surgery, and postoperative intraperitoneal therapy. The consensus aims to standardize clinical practice and improve the prognosis of patients with GCPM.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Prognostic comparison between breast-conserving surgery combined with radiotherapy and total mastectomy in patients with triple-negative invasive lobular carcinoma: a SEER database-based study
    WANG Xinping, YU Zhun, YUAN Shuai, TANG Yongzhe
    Journal of Surgery Concepts & Practice    2025, 30 (03): 256-263.   DOI: 10.16139/j.1007-9610.2025.03.12
    Abstract490)   HTML5)    PDF(pc) (1038KB)(432)       Save

    Objective To investigate the prognosis of patients with triple-negative invasive lobular carcinoma (TN-ILC) undergoing breast-conserving surgery combined with radiotherapy (BCS+RT) versus total mastectomy. Methods A retrospective analysis was performed for 2 386 female patients with TN-ILC who underwent surgery in the SEER database from 2006 to 2018, and the baseline characteristics (age, histological grade, AJCC stage, etc.) were balanced by propensity score matching (PSM, 1∶1, caliper value 0.02), and breast cancer-specific survival (BCSS) and overall survival (OS) were compared by Kaplan-Meier method and COX regression analysis. Results A total of 1 056 pairs of patients were obtained after PSM, and the BCS+RT group had significantly better BCSS and OS than the total mastectomy group (both P<0.001). Stratified analyses showed that BCS+RT had a survival advantage in all subgroups except histologic grade Ⅰ and tumor stage Ⅰ. Multivariate analysis confirmed that BCS+RT was an independent protective factor (BCSS: HR=0.682, OS: HR=0.607, both P<0.001). Conclusions BCS+RT significantly improves survival compared with total mastectomy in patients with TN-ILC, supporting BCS+RT as the preferred treatment strategy for eligible patients.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Progression in circulating tumor DNA detection for minimal residual disease in patients with colorectal cancer liver metastasis
    LI Yaqi, MO Shaobo, PENG Junjie
    Journal of Surgery Concepts & Practice    2025, 30 (04): 351-357.   DOI: 10.16139/j.1007-9610.2025.04.10
    Abstract380)   HTML4)    PDF(pc) (982KB)(175)       Save

    As a non-invasive biomarker, circulating tumor DNA (ctDNA) can sensitively identify minimal residual disease (MRD), offering a novel approach for prognosis prediction and efficacy evaluation in patients with colorectal cancer liver metastasis (CRLM), thereby aiding in the formulation of personalized treatment strategies. This article summarized the progress in the application of ctDNA detection for MRD in CRLM and provided insights into its future directions.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Controversial points in the surgical treatment of gallbladder cancer with delayed diagnoses
    LE Sen, ZUO Yue, DENG Zhengdong, WANG Jianming
    Journal of Surgery Concepts & Practice    2025, 30 (02): 106-111.   DOI: 10.16139/j.1007-9610.2025.02.03
    Abstract364)   HTML7)    PDF(pc) (908KB)(173)       Save

    Gallbladder cancer with delayed diagnoses, as a malignant tumor diagnosed intraoperatively or postoperatively incidentally in benign gallbladder diseases, radical surgical treatment is its core treatment, and the necessity of re-operation, timing of surgery, choice of surgical procedure, definition of resection extent, and preoperative neoadjuvant therapy still remain controversial. Re-operation for gallbladder cancer with delayed diagnoses needs to balance tumor radicalization, postoperative risk, and survival benefit, and combining neoadjuvant therapy to facilitate radical treatment, and develop individualized protocols. The multidisciplinary team should integrate innovative technologies and multi-center prospective studies to promote the development of precise treatment strategies for gallbladder cancer with delayed diagnoses and optimize the survival of patients.

    Reference | Related Articles | Metrics | Comments0
    Prevention and management of immune-related adverse events for biliary tract cancers
    LIU Kun, GUO Wei
    Journal of Surgery Concepts & Practice    2025, 30 (02): 112-119.   DOI: 10.16139/j.1007-9610.2025.02.04
    Abstract362)   HTML6)    PDF(pc) (1001KB)(245)       Save

    Immune checkpoint inhibitors (ICIs) combined with chemotherapy has become the first-line standard treatment for advanced biliary tract cancers (BTC). However, the application of ICIs comes with its risks of immune-related adverse events (irAEs). BTC patients often face greater challenges in the diagnosis and management of irAEs, especially in the differential diagnosis of immune related hepatitis, due to the presence of special conditions such as underlying liver dysfunction and biliary obstruction. We aimed to systematically review the current status of BTC immunotherapy, the spectrum of irAEs, clinical characteristics, prevention strategies, and management principles. We focused to investigate the specificity and response measures of irAEs management in BTC patients, optimizing immunotherapy management for BTC patients, maximizing treatment benefits and ensuring patient safety, and exploring the future research directions.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Clinical controversy and research progress of post-cholecystectomy syndrome
    WU Yuzhao, CAI Jie, CHEN Shenhao, CHEN Xi, ZHENG Yamin
    Journal of Surgery Concepts & Practice    2025, 30 (03): 268-271.   DOI: 10.16139/j.1007-9610.2025.03.14
    Abstract357)   HTML5)    PDF(pc) (860KB)(245)       Save

    Post-cholecystectomy syndrome (PCS) encompasses persistent or new abdominal pain, bloating, and diarrhea following cholecystectomy. Our understanding of its etiology, diagnosis, and treatment has evolved significantly. This systematic review traced the conceptual progression of PCS and addressed clinical controversies, and reflections on diagnostic and therapeutic improvements. The definition of PCS has shifted from an anatomical focus (e.g., retained stones, biliary duct injury) to functional disorders (e.g., sphincter of Oddi dysfunction, abnormal bile acid metabolism, and psychosomatic factors). Current diagnosis strictly adheres to the Rome Ⅳ criteria, with an approximate prevalence of 10%. Historically broad diagnostic criteria explained the wide variability in reported incidence rates (5%-63%). Ambiguity persists regarding whether pre-existing symptoms persisting or evolving postoperatively should be attributed to PCS.Therapeutic approaches have transitioned from definitive surgical interventions for organic lesions to pharmacological management of functional dyspepsia. Given the inherent conceptual ambiguity in PCS, we proposed replacing PCS with ​post-cholecystectomy biliary dyspepsia (PCBD)—a term emphasizing its postoperative onset, functional dyspepsia characteristics, and exclusion of preoperative symptoms or non-biliary etiologies. The introduction of the concept of PCBD can help to unify diagnostic criteria, guide individualized treatment, and conduct in-depth research.

    Reference | Related Articles | Metrics | Comments0
    Systemic therapy for advanced cholangiocarcinoma: divergences in global guidelines and regional clinical implementation
    LI Chun, MA Zuyi, SUN Jia, LI Binglu
    Journal of Surgery Concepts & Practice    2025, 30 (02): 93-100.   DOI: 10.16139/j.1007-9610.2025.02.01
    Abstract356)   HTML13)    PDF(pc) (1032KB)(443)       Save

    Cholangiocarcinoma (CCA) is a group of malignant tumors arising from the biliary epithelium, with systemic therapy serving as the primary treatment approach for patients with advanced disease. In recent years, advances in molecular classification and targeted therapy have led to rapid updates in treatment guidelines for CCA. This review summarized recent progress in systemic treatment strategies for advanced CCA and the relevant recommendations in both international and domestic guidelines, aiming to provide evidence-based references for clinical management and decision-making in patients with CCA.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Evolution and hot topics of laparoscopic sphincter-preserving surgery for low rectal cancer
    ZHI Yihao, ZHAO Xuan, ZHENG Minhua
    Journal of Surgery Concepts & Practice    2025, 30 (04): 358-363.   DOI: 10.16139/j.1007-9610.2025.04.11
    Abstract348)   HTML3)    PDF(pc) (872KB)(149)       Save

    Rectal cancer is a prevalent malignant tumor both in China and worldwide. Despite the availability of numerous sphincter-preserving procedures for low rectal cancer, each with specific indications, advantages, and limitations, no single procedure achieves optimal outcomes in all key domains: anal function preservation, surgical complication reduction, local recurrence rate minimization, and patient quality of life improvement. This article reviewed the evolutionary trajectory of laparoscopic sphincter-preserving surgery for low rectal cancer, while addressing current surgical challenges including prevention and management of anastomotic leakage, strategies for ensuring adequate distal resection margins, and functional outcomes prognosis. Corresponding countermeasures for these critical issues were systematically discussed.

    Reference | Related Articles | Metrics | Comments0
    Incidence and mortality analysis of biliary tract cancer in Shanghai: population-based study from 2002 to 2020
    WU Chunxiao, PANG Yi, CHEN Lei, SHI Yan, GU Kai
    Journal of Surgery Concepts & Practice    2025, 30 (03): 214-222.   DOI: 10.16139/j.1007-9610.2025.03.06
    Abstract343)   HTML13)    PDF(pc) (1024KB)(157)       Save

    Objective To analyze the epidemiological characteristics and trends of the incidence and mortality of biliary tract cancer in Shanghai from 2002 to 2020. Methods Data on new cases and deaths of malignant tumors of the gallbladder, extrahepatic bile ducts, and other biliary tract organs from 2002 to 2020 were obtained from the Population-based Cancer Registry and Vital Statistics System of Shanghai Municipal Center for Disease Control and Prevention. Cases or deaths, proportion, crude rate, age-specific rate, age-standardized rate (ASR) and others were calculated stratified by year of diagnosis or death, gender and age-group. ASRs were calculated using Segi′s 1960 world standard population. Trends of the annual percent change (APC) of ASRs, age-specific rates and proportions of new cases with selected diagnostic character of biliary tract cancer stratified by different groups were analyzed by Joinpoint analysis software. Results Annual new cases of biliary tract cancer in Shanghai increased from 963 in 2002 to 1 537 in 2020, with ASR of incidence changing from 3.91/10⁵ to 3.59/10⁵. Annual deaths increased from 830 to 1 225, with ASR of mortality decreased from 3.36/10⁵ to 2.69/10⁵. In 2020, the crude rate of incidence of biliary tract cancer was 10.43/10⁵ (9.54/10⁵ in males and 11.30/10⁵ in females) in Shanghai, and the ASR was 3.59/10⁵ (3.54/10⁵ in males and 3.61/10⁵ in females), with no statistically significant gender difference (P=0.731). The crude rate of mortality was 8.31/10⁵ (7.60/10⁵ in males and 9.00/10⁵ in females), and the ASR was 2.69/10⁵ (2.69/10⁵ in males and 2.66/10⁵ in females), also with no significant gender difference (P=0.874). Age-specific nunbers and rates of incidence and mortality generally increased with aging. Stratified by gender, the trend of ASRs of incidence of biliary tract cancer in Shanghai in males showed no significant change (P=0.179) from 2002 to 2020, nor did that of ASRs of mortality (P=0.738). In females, the ASRs of incidence decreased at an average annual rate of 1.58% (P<0.001), while the trend of ASRs of mortality showed no significant change from 2002 to 2011 (P=0.774), but ASRs decreased at an average annual rate of 3.72% from 2011 to 2020 (P<0.001). Among new cases, the proportions of morphological verification increased, while the proportions of imaging verification decreased. The gallbladder was the most common site, but its proportions decreased significantly, whereas the proportions of extrahepatic bile duct increased from 25.75% to 42.88%. Over 60% of cases were unknown stage at diagnosis, while the combined proportions of stages Ⅰ-Ⅲ remained less than that of stage Ⅳ. Conclusions The ASRs for incidence and mortality of biliary tract cancer in Shanghai remain relatively high, with distinct epidemiological characteristics. The improvement in the diagnosis and treatment of biliary diseases maybe have impact on the incidence patterns of biliary tract cancer in Shanghai, but the effect on increasing survival rates and reducing mortality rates is relatively lagging. It needs a big progress to advance the screening, diagnosis, and survival of biliary tract cancer in Shanghai. This study provides a foundation for further research and prevention strategies for biliary tract cancer.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Research progress on the immune microenvironment and immunotherapy of thyroid cancer
    LIAO Zhenyu, ZHU Wenxin, YAN Jiqi
    Journal of Surgery Concepts & Practice    2025, 30 (02): 165-170.   DOI: 10.16139/j.1007-9610.2025.02.12
    Abstract341)   HTML6)    PDF(pc) (1255KB)(334)       Save

    Thyroid cancer is the most common endocrine malignancy. Although most patients achieve good prognosis through surgery and conventional treatments, approximately 15%-20% of patients with papillary thyroid cancer and the anaplastic and medullary thyroid cancers still lack effective treatment options. The tumor immune microenvironment plays a critical role in the occurrence, progression, and drug resistance of thyroid cancer. This review focused on the key immune cells in thyroid cancer, including tumor-associated macrophages, myeloid-derived suppressor cells, mast cells, natural killer cells, and T lymphocytes, and explored their roles and mechanisms in tumor immune evasion. Immunotherapy has become an emerging treatment strategy for advanced thyroid cancer, we summarized the attempts and advances in immune checkpoint inhibitors, targeted macrophage therapy and tumor vaccines.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Application experience of the cross-shaped coordinate line localization method in laparoscopic cholecystectomy
    LIANG Yong, SUN Jing, WU Weize
    Journal of Surgery Concepts & Practice    2025, 30 (05): 417-422.   DOI: 10.16139/j.1007-9610.2025.05.07
    Abstract334)   HTML5)    PDF(pc) (5751KB)(127)       Save

    Objective To explore the application of the “cross-shaped coordinate line localization method” in laparoscopic cholecystectomy (LC) to realize critical view of safety (CVS) as well as summarize its safety and practicality. Methods Eighty-four patients who were treated with the “cross-shaped coordinate line localization method” at the Department of General Surgery of Wuxi Branch of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine from February 2020 to February 2023 were selected as the observation group, and 84 patients who were randomly selected to receive the traditional LC treatment during the same period were selected as the control group. In the observation group, the “cross-shaped coordinate line localization method” was used as the boundary mark to reach CVS, and complete cholecystectomy. In the control group, the traditional blunt and sharp operation methods were used to free gallbladder triangle, and dissect out the cystic ducts and cystic arteries one by one and ligate them off. The intraoperative, postoperative and related complications of the two groups were compared and analyzed. Results All 168 patients successfully completed LC without serious surgical complications or conversion to open cases. The observation group took longer operation time to than the control group [(89.5±12.3) min vs. (67.7±8.9) min, P<0.001), and intraoperative blood loss was less than the control group [(7.0±3.9) mL vs. (15.2±4.6) mL, P<0.001). The rate of biliary and vascular anomalies in the observation group was higher than that in the control group (9.5% vs. 1.2%, P=0.040). The observation group had higher mobility on the first postoperative day than the control group, and time to first postoperative feeding and time to first postoperative flatus were earlier than those of the control group (P<0.05). The overall incidence rate of related complications in the observation group was lower than that in the control group (2.4% vs. 10.7%, P=0.029). There was no statistically significant difference between the two groups in terms of drain placement and length of hospital stay (P>0.05). Conclusions The “cross-shaped coordinate line localization method”, with its constant anatomical position as the basic symbol, can help surgeons quickly lock the safe operation area and realize CVS of the gallbladder triangle to avoid bile duct injury and reduce the incidence of related complications.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Efficacy variations of adjuvant chemotherapy across disease stages in duodenal adenocarcinoma: a multivariate survival analysis based on the SEER database
    WANG Yu, HU Kaixin, ZHAO Fengqing, LI Huangbao
    Journal of Surgery Concepts & Practice    2025, 30 (05): 428-437.   DOI: 10.16139/j.1007-9610.2025.05.09
    Abstract307)   HTML5)    PDF(pc) (951KB)(201)       Save

    Objective To investigate the efficacy of adjuvant chemotherapy for patients with duodenal adenocarcinoma (DAC) at different stages. Methods A retrospective analysis was performed on patients diagnosed with DAC between January 2000 and December 2021 using data from the SEER database. Kaplan-Meier curves were utilized to evaluate the impact of adjuvant chemotherapy on survival outcomes in DAC patients with different stages. Univariate and multivariate COX regression analyses were performed to determine whether adjuvant chemotherapy served as an independent prognostic factor for cancer-specific survival (CSS) and overall survival (OS). Results A total of 1 195 patients meeting the inclusion criteria were included in the study. Of these, 620 patients (51.9%) received adjuvant chemotherapy after surgery were defined as the adjuvant chemotherapy group, whereas 575 patients (48.1%) underwent surgery alone were defined as the other group. After propensity score matching, 634 patients were retained for subsequent analysis. Subgroup analysis demonstrated that there were statistically significant differences in CSS and OS between the adjuvant chemotherapy group and other group for stage ⅢA and ⅢB patients (P < 0.05), while no statistically significant differences in CSS and OS between the adjuvant chemotherapy group and other group for stageⅠ, stageⅡA, stage ⅡB patients (P > 0.05). Multivariate analysis identified adjuvant chemotherapy as an independent protective factor for both CSS and OS in DAC patients. Additionally, age, year of diagnosis, tumor grade, number of regional lymph nodes examined (RNE), and TNM stage were identified as independent protective or risk factors for CSS and OS (all P < 0.05). Conclusions Based on substage stratification, the survival benefits of adjuvant chemotherapy for DAC patients are as follows: patients with stage ⅢA and ⅢB benefit in both CSS and OS, while patients with stage Ⅰ, Ⅱ A, and ⅡB do not benefit in either CSS or OS.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Interpretation of the 2025 American Society for Gastrointestinal Endoscopy guideline on diagnosis and management of GERD
    SANG Huaiming, WU Gaojue, TANG Yurong
    Journal of Surgery Concepts & Practice    2025, 30 (05): 385-391.   DOI: 10.16139/j.1007-9610.2025.05.03
    Abstract297)   HTML23)    PDF(pc) (1002KB)(595)       Save

    Released in February 2025, American Society for Gastrointestinal Endoscopy(ASGE) guideline on the diagnosis and management of gastroesophageal reflux disease(GERD), is based on a large body of evidence-based medical evidence over the past decade. It has systematically updated the indications for endoscopic examination, standards for high-quality endoscopic examination, and multidimensional management strategies, while focusing on elucidating the new role of endoscopic intervention in the diagnosis and treatment of GERD. The guideline aimed to provide clinicians with an authoritative guiding tool that integrates both scientific and practical value.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Comprehensive diagnosis and treatment strategy for functional pancreas neuroendocrine neoplasm: a report of 3 cases
    JI Bei, SHANG Zhengye, TUO Biguang, LIU Xuemei
    Journal of Surgery Concepts & Practice    2025, 30 (05): 438-443.   DOI: 10.16139/j.1007-9610.2025.05.10
    Abstract297)   HTML2)    PDF(pc) (4723KB)(155)       Save

    Functional neuroendocrine neoplasm, which secrete hormones and lead to diverse clinical symptoms, pose significant challenges in diagnosis and treatment. Early identification and standardized management are crucial for improving patient prognosis. This article summarized three clinically relatively common cases of Functional pancreatic neuroendocrine neoplasm (F-pNENs), focusing on analyzing their diagnostic key points and standardized therapeutic pathways. It aimed to provide reference for early clinical identification of rare tumors and improvement of standardized multidisciplinary diagnosis and treatment as well as personalized treatment strategies.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Intraoperative margin assessment techniques in breast-conserving surgery: current status and advances
    JIN Xiaoding, ZOU Qiang, JIN Yiting
    Journal of Surgery Concepts & Practice    2025, 30 (02): 176-182.   DOI: 10.16139/j.1007-9610.2025.02.14
    Abstract291)   HTML7)    PDF(pc) (899KB)(239)       Save

    In breast-conserving surgery, timely and accurate intraoperative margin assessment is crucial for ensuring surgical success and reducing local recurrence rates. This review first outlined the current methods for intraoperative margin evaluation, including rapid pathological examination and specimen imaging techniques. According to the technical classification, this review systematically introduced emerging technologies that have advanced significantly in recent years, encompassing advanced microscopy, advancements in conventional imaging technologies, novel imaging technologies, and techniques based on biochemical and electrical property contrasts of tissues. Finally, the review summarized and compared these technologies horizontally, and proposed several assessment dimensions aligned with surgical clinical needs, aiming to support the optimization and clinical translation of intraoperative margin assessment techniques. Despite the vigorous development of new technologies, further clinical research and technical refinement remain necessary to achieve continuous improvement and innovation, ultimately providing better options for the patients.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    The relationship between blood glucose variability, disease severity and prognosis of the patients with acute pancreatitis
    ZHU Shiyi, LU Tingting, XIE Rongli, TAN Dan, FEI Jian, CHEN Erzhen, CHEN Ying, XIA Yi
    Journal of Surgery Concepts & Practice    2025, 30 (03): 223-227.   DOI: 10.16139/j.1007-9610.2025.03.07
    Abstract281)   HTML8)    PDF(pc) (987KB)(256)       Save

    Objective To explore the relationship between blood glucose variability, disease severity and prognosis of the patients with acute pancreatitis. Methods Total of 242 patients with acute pancreatitis admitted to the department of emergency from January 2019 to December 2019 were enrolled. The organ failure was evaluated according to Marshall's score, the severity of the disease was evaluated according to Atlanta's score, and the blood glucose indexes of three groups of patients with mild acute pancreatitis, moderate severe acute pancreatitis and severe acute pancreatitis were compared within seven days after admission. The relationship between blood glucose index and disease severity in different patients with acute pancreatitis was analyzed. Taking whether a puncture was performed at admission, whether the patient was admitted to the intensive care unit (ICU), and whether the patient died as endpoint events as classification factors, the relationship between blood glucose indicators and disease prognosis of patients with acute pancreatitis was analyzed using the One-Way ANOVA, Kruskal-Wallis test, Mann-Whitney U test, receiver operating characteristic curve (ROC curve), etc. Results Of the 242 patients, 70 cases (28.9%) were mild acute pancreatitis, 71 cases (29.3%) with moderate severe acute pancreatitis, 101 cases (41.7%) with severe acute pancreatitis. There was no statistically significant difference in the coefficient of variation of blood glucose among the three groups within 7 days of admission. The mean, standard deviation, maximum, minimum value and difference between maximum and minimum value of venous blood glucose in severe acute pancreatitis group were higher than those in moderate severe acute pancreatitis group, while those in moderate severe acute pancreatitis group were higher than those in mild acute pancreatitis group. The mean value of blood glucose of invasive operation group (IOP) (n=55) was higher than that of non-invasive operation (NOP) group(n=187). Conclusions The blood glucose level and fluctuation range of patients with acute pancreatitis within seven days after admission, are of great significance for the judgment of the severity and prognosis of the disease.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Current status and reflections on immunotherapy and targeted therapy for unresectable biliary tract cancer
    YU Liqin, YAN Xiaoyu, WANG Puxiongzhi, WANG Wei, WANG Jian
    Journal of Surgery Concepts & Practice    2025, 30 (06): 544-550.   DOI: 10.16139/j.1007-9610.2025.06.14
    Abstract277)   HTML2)    PDF(pc) (939KB)(35)       Save

    Biliary tract cancer (BTC) represents a group of highly malignant solid tumors with a five-year survival rate of only 10%. For patients with unresectable BTC, gemcitabine combined with cisplatin has been the conventional first-line treatment regimen. With the remarkable efficacy of immunotherapy and targeted therapy observed in other solid tumors, numerous studies have investigated their potential in unresectable BTC. This article provides an overview of the current status of targeted and immunotherapeutic approaches for unresectable BTC, with a focus on research advancements in immune checkpoint inhibitor (ICI) and targeted agents against fibroblast growth factor receptor(FGFR), isocitrate dehydrogenase(IDH), and human epidermal growth factor receptor 2(HER2), as well as future trends in immunotherapy and targeted therapy, aiming to contribute to the development of more effective treatment strategies.

    Reference | Related Articles | Metrics | Comments0